About Cardival Medical
Cardival Medical is a Healthcare company based in Santa Clara (United States) founded in 2002, and was acquired by Haemonetics in January 2021. A device for vascular access management is developed. Cardival Medical has raised $169.45 million across 13 funding rounds from investors including Haemonetics, GE Capital and WI Harper Group. The company has 158 employees. Cardival Medical offers products and services including Cell Saver, TEG 6s, and VASCADE. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is CARDIVA MEDICAL, INC. Its competitors include Saranas, Aziyo Biologics and Cordis; 2 of its 3 listed competitors have raised funding.
Company details
Cardival Medical was founded in 2002 in Santa Clara, United States, where medical devices for vascular access are developed. Operations center on two products: Vascade, an extravascular bioabsorbable femoral access closure system, and CATALYST, used for temporary hemostasis and coagulation support in patients. The focus remains on vascular sector innovations, with activities based in the United States.
- Headquarters Santa Clara, United States
- Employees 158
- Stage Acquired
- SectorsHealthcare
- Website cardivamedical.com
- Social LinkedIn X Facebook
- Acquired by Haemonetics (Jan 2021)
- Legal Name Cardiva Medical, Inc.
- Total Equity Funding$169.45M (USD)
in 13 rounds
- Latest Funding Round$45M (USD), Series E
Jul 2020
- InvestorsHaemonetics
& 9 more
- Employee Count158
- Acquired byHaemonetics
(Jan 2021)
Products & Services of Cardival Medical
Cardival Medical offers a comprehensive portfolio of products and services, including Cell Saver, TEG 6s, and VASCADE.
Device for recovering blood during surgical procedures
System for monitoring and analyzing blood clotting functions
Tool for sealing vascular access sites post-procedure
Funding Insights of Cardival Medical
Cardival Medical has successfully raised a total of $169.45M across 13 strategic funding rounds. The most recent funding activity was a Series E round of $45 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $169.45M
- Total Rounds 13
- Last Round Series E β $45M
- First Round $10.5M
(Nov 2003)
- Investors Count 9
Latest 10 of 13 funding rounds of Cardival Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $45M | Series E | β | β | β |
| Feb 2018 | Series D | β | β | ||
| Feb 2018 | Debt – Conventional | β | β | ||
| Jan 2018 | $39.24M | Series D | β | LKCM | |
| Aug 2014 | $16.5M | Series D | β | β | |
| Aug 2014 | $12.5M | Debt – Conventional | β | β | |
| Jul 2013 | $3.5M | Series D | β | β | β |
| Mar 2013 | $16.93M | Series D | β | β | |
| Aug 2012 | Series D | β | β | β | |
| May 2008 | $15.5M | Series D | β | β |
10 investors in total: 10 institutional.
Investors in Cardival Medical
Cardival Medical has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Haemonetics, GE Capital and WI Harper Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life Sciences focused VC firm investing in expansion & late stage start-ups in the US | 2003 | ptvhc.com | Austin, United States | |
| canepahealthcare.com | ||||
Investment management services are provided by Luther King Capital Management. | 1979 | lkcm.com | Fort Worth, United States | |
| amkeyvc.com | ||||
PE firm investing in the US | galen.com | Stamford, United States | ||
| sycaventures.com | ||||
| harbingervc.com | ||||
VC firm that does investment in early stage companies in the US & China | 1993 | wiharper.com | San Francisco, United States | |
Commercial aircraft and equipment leasing and lending services are provided. | 1932 | gecapital.com | United States | |
Hematology products and solutions are provided for medical applications. | 1971 | haemonetics.com | Braintree, United States |
Investor details for Cardival Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cardival Medical
4 dated milestones of Cardival Medical across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Cardival Medical is founded.
- Funding First funding round of $10.5M.
- Funding Latest funding round, Series E, of $45.0M.
- Exit Acquired by Haemonetics.
Competitors of Cardival Medical
Cardival Medical has 3 listed competitors in our database, 2 of them funded. They include Saranas, Aziyo Biologics and Cordis.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| saranas.com | 2011 | Houston, United States | $29.46M | A device is developed for detecting internal bleeding during catheterization. | ||
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. | |
| cordis.com | 1957 | Fremont, United States | 5 | Cardiovascular and endovascular devices are developed and marketed by Cordis. |
Detailed competitors of Cardival Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Cardival Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cardival Medical
Complete news archive for Cardival Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cardival Medical
Cardival Medical was founded in 2002 and raised its 1st funding round 1 year after it was founded.
Cardival Medical is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Cardival Medical is a funded company, having raised a total of $169.45M across 13 funding rounds to date. The company's 1st funding round was a Series D of $15.5M, raised on Nov 2003.
Cardival Medical has 158 employees.
Cardival Medical was founded in 2002 in Santa Clara, United States, where medical devices for vascular access are developed. Operations center on two products: Vascade, an extravascular bioabsorbable femoral access closure system, and CATALYST, used for temporary hemostasis and coagulation support in patients. The focus remains on vascular sector innovations, with activities based in the United States.
Cardival Medical's top competitors include Aziyo Biologics, Cordis and Saranas.
Cardival Medical offers Cell Saver, TEG 6s, and VASCADE.
Cardival Medical has 10 investors. Key investors include Haemonetics, GE Capital, WI Harper Group, PTV Healthcare Capital, and Canepa Healthcare.
Cardival Medical operates through Cardiva Medical, Inc..
Yes. Cardival Medical was acquired by Haemonetics in January 2021.

